TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8998091

Group type: EXPERIMENTAL
Intervention: Verapamil-quinidine (VER-Q)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Digoxin-quinidine (DIG-Q)
Number of subjects: 44
Study: 8438824

Group type: EXPERIMENTAL
Intervention: Automated incision device
Number of subjects: 40

Group type: COMPARATOR
Intervention: Lancet puncture device
Number of subjects: 40
Study: 3553493

Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 626

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 626

Group type: EXPERIMENTAL
Intervention: Methyldopa
Number of subjects: 626

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (added to treatment)
Number of subjects: 626
Study: 30772211

Group type: EXPERIMENTAL
Intervention: Acuvue Bifocal
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Center-near multifocal lenses
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Center-distance multifocal lenses
Number of subjects: 44

Group type: COMPARATOR
Intervention: Single vision control (Air Optix Aqua)
Number of subjects: 44
Study: 30257696

Group type: EXPERIMENTAL
Intervention: Silver diamine fluoride and fluoride varnish
Number of subjects: 0

Group type: COMPARATOR
Intervention: Glass ionomer therapeutic sealants and fluoride varnish
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Care provided by nurses
Number of subjects: 0

Group type: COMPARATOR
Intervention: Care provided by dental hygienists
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prevention measures
Number of subjects: 0
Study: 27869225

Group type: EXPERIMENTAL
Intervention: Noisy galvanic vestibular stimulation (nGVS) for 30 minutes twice with a 4-hour interval
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Noisy galvanic vestibular stimulation (nGVS) for 3 hours
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Noisy galvanic vestibular stimulation (nGVS)
Number of subjects: 30
Study: 24464974

Group type: EXPERIMENTAL
Intervention: Aerosolized tobramycin 300 mg/4 ml (TNS4)
Number of subjects: 321

Group type: COMPARATOR
Intervention: Aerosolized tobramycin 300 mg/5 ml (TNS5)
Number of subjects: 321
Study: 24341502

Group type: EXPERIMENTAL
Intervention: Blended-learning approach (BL)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Didactic approach (DID)
Number of subjects: 61
Study: 20203108

Group type: EXPERIMENTAL
Intervention: Tobacco use intervention
Number of subjects: 5603

Group type: COMPARATOR
Intervention: Health education control intervention
Number of subjects: 5603
Study: 17765380

Group type: EXPERIMENTAL
Intervention: Modafinil (200-300 mg/day depending on weight)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Methylphenidate (20-30 mg/day depending on weight)
Number of subjects: 60
Study: 15754390

Group type: EXPERIMENTAL
Intervention: Corticosteroids at 60 mg or more daily with or without anti-viral drugs within 10 days after diagnosis (early high-dose group)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Non-early high-dose group (treated more than 10 days or untreated with corticosteroids)
Number of subjects: 22
Study: 12760310

Group type: COMPARATOR
Intervention: Myoglobin levels at admission
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Troponin T (TnT) levels at 2 hours
Number of subjects: 33

Group type: COMPARATOR
Intervention: Creatinine Kinase (CK) levels
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: All tests after 4 hours
Number of subjects: 33
Study: 10234944

Group type: EXPERIMENTAL
Intervention: Synthetic antioxidants (dibunol, probucol, emoxipine)
Number of subjects: 202

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 202
Study: 8990830

Group type: EXPERIMENTAL
Intervention: Clomiphene citrate
Number of subjects: 0
Study: 1862894

Group type: EXPERIMENTAL
Intervention: Patient-controlled sedation with propofol
Number of subjects: 40

Group type: COMPARATOR
Intervention: Midazolam and fentanyl (control)
Number of subjects: 40
Study: 6192894

Group type: EXPERIMENTAL
Intervention: CPOB (cyclophosphamide on day 1, prednisone on days 1 to 5, vincristine and bleomycin on day 15 of each 21-day cycle)
Number of subjects: 90

Group type: COMPARATOR
Intervention: COPB (cyclophosphamide, prednisone, vincristine and bleomycin on day 1)
Number of subjects: 90

Group type: COMPARATOR
Intervention: BCVP (maintenance therapy for responders)
Number of subjects: 90

Group type: COMPARATOR
Intervention: COPA (maintenance therapy for responders)
Number of subjects: 90
Study: 31958178

Group type: EXPERIMENTAL
Intervention: Everolimus with early CNI elimination
Number of subjects: 115

Group type: COMPARATOR
Intervention: CNI-based immunosuppression
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: ACR (1R, 2R, 3R)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: 1R
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Mild ACR
Number of subjects: 115
Study: 30692186

Group type: EXPERIMENTAL
Intervention: Simplified method for complete denture fabrication
Number of subjects: 36

Group type: COMPARATOR
Intervention: Conventional method for complete denture fabrication
Number of subjects: 36
Study: 28478716

Group type: EXPERIMENTAL
Intervention: Valerian (530 mg) nightly 1 hour before sleep for 4 weeks
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo nightly 1 hour before sleep for 4 weeks
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Valerian
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 27078988

Group type: EXPERIMENTAL
Intervention: MSBD + CAG
Number of subjects: 46

Group type: COMPARATOR
Intervention: CAG + placebos
Number of subjects: 46
Study: 24722261

Group type: EXPERIMENTAL
Intervention: MDCO-2010 (4/24 patients, 17%)
Number of subjects: 32

Group type: COMPARATOR
Intervention: MDCO-2010 (highest dosage groups)
Number of subjects: 32
Study: 22999984

Group type: EXPERIMENTAL
Intervention: Anesthesia group (LMA removal during anesthesia with 2.2% sevoflurane)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Awake group (LMA removal when patients met recovery criteria)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Anesthesia group
Number of subjects: 92

Group type: COMPARATOR
Intervention: Awake group
Number of subjects: 92
Study: 19201291

Group type: EXPERIMENTAL
Intervention: Rapid Rhino tampon
Number of subjects: 13

Group type: COMPARATOR
Intervention: Rhino Rocket tampon
Number of subjects: 13
Study: 18067483

Group type: EXPERIMENTAL
Intervention: Calcipotriol ointment twice daily
Number of subjects: 106

Group type: COMPARATOR
Intervention: Dithranol cream once daily
Number of subjects: 106
Study: 15788020

Group type: EXPERIMENTAL
Intervention: Protein-rich liquid supplement (PR; 200 kcal and 20 g protein day(-1))
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Protein-rich liquid supplement (PR; 200 kcal and 20 g protein day(-1)) + nandrolone decanoate injections (PR/N) 25 mg i.m. every third week
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 45
Study: 11849631

Group type: EXPERIMENTAL
Intervention: Ortho Evra/Evra transdermal patch (3 consecutive 7-day patches for 21 days with 1 patch-free week)
Number of subjects: 3319

Group type: EXPERIMENTAL
Intervention: Ortho Evra/Evra transdermal patch
Number of subjects: 3319
Study: 10450383

Group type: EXPERIMENTAL
Intervention: 0.5 ml carbachol intracamerally (carbachol group)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Balanced salt solution intracamerally (control group)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 51
Study: 7761314

Group type: EXPERIMENTAL
Intervention: Arthroscopic ACL reconstruction
Number of subjects: 0

Group type: COMPARATOR
Intervention: Open ACL reconstruction
Number of subjects: 0
Study: 2246784

Group type: EXPERIMENTAL
Intervention: Informational video
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: Emotionally involving video
Number of subjects: 312

Group type: COMPARATOR
Intervention: Control video
Number of subjects: 312
Study: 6101459

Group type: EXPERIMENTAL
Intervention: 3 mg synthetic beta-endorphin
Number of subjects: 14
Study: 31511330

Group type: EXPERIMENTAL
Intervention: Fingolimod 0.5 mg/d
Number of subjects: 823

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 823
Study: 28840622

Group type: EXPERIMENTAL
Intervention: Propolis with 8%-12% galangin plus mouth rinsing with sodium bicarbonate
Number of subjects: 60

Group type: COMPARATOR
Intervention: Mouth rinsing with sodium bicarbonate
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Propolis plus bicarbonate
Number of subjects: 60
Study: 26370380

Group type: EXPERIMENTAL
Intervention: MedDiet supplemented with extravirgin olive oil (MedDiet+EVOO)
Number of subjects: 3614

Group type: EXPERIMENTAL
Intervention: MedDiet supplemented with mixed nuts (MedDiet+Nuts)
Number of subjects: 3614

Group type: COMPARATOR
Intervention: Low-fat control diet
Number of subjects: 3614

Group type: EXPERIMENTAL
Intervention: MedDiet adherence (highest vs lowest quintile)
Number of subjects: 3614
Study: 23673286

Group type: EXPERIMENTAL
Intervention: LPS (0.4ng/kg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 16
Study: 21175373

Group type: EXPERIMENTAL
Intervention: Solifenacin 5 mg/day
Number of subjects: 132

Group type: COMPARATOR
Intervention: Oxybutynin IR 15 mg/day
Number of subjects: 132
Study: 19411362

Group type: EXPERIMENTAL
Intervention: Clinical vignettes manipulating expected progress and patient adherence to treatment
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Adding guideline variables (short-term progress assessment, current condition, and guideline step)
Number of subjects: 21
Study: 17713338

Group type: EXPERIMENTAL
Intervention: Sugar-free gum containing 20 mg citric acid and 18.8 mg CPP-ACP
Number of subjects: 10

Group type: COMPARATOR
Intervention: Sugar-free gum containing 20 mg citric acid alone
Number of subjects: 10

Group type: COMPARATOR
Intervention: Sugar-free gum not containing CPP-ACP or citric acid
Number of subjects: 10
Study: 14960434

Group type: EXPERIMENTAL
Intervention: Moderate alcohol consumption
Number of subjects: 14962

Group type: COMPARATOR
Intervention: Non-drinkers
Number of subjects: 14962
Study: 11254818

Group type: EXPERIMENTAL
Intervention: Oral corticosteroids (median prednisolone dose 61 g)
Number of subjects: 367

Group type: EXPERIMENTAL
Intervention: Oral corticosteroids
Number of subjects: 367
Study: 9013361

Group type: EXPERIMENTAL
Intervention: Patients with cerebral infarction
Number of subjects: 6

Group type: COMPARATOR
Intervention: Age-matched controls with SAS
Number of subjects: 6
Study: 8162731

Group type: EXPERIMENTAL
Intervention: Methacholine
Number of subjects: 19

Group type: COMPARATOR
Intervention: Provocholine
Number of subjects: 19
Study: 3278494

Group type: EXPERIMENTAL
Intervention: Butorphanol, mean dose 4.8 ± 0.4 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Diazepam, mean dose 12.0 ± 1.0 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 0
Study: 30758896

Group type: EXPERIMENTAL
Intervention: 30 Hz vibration
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 60 Hz vibration
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 28707325

Group type: EXPERIMENTAL
Intervention: Scalp nerve block with 0.25% ropivacaine after intubation
Number of subjects: 44

Group type: COMPARATOR
Intervention: Remifentanil 1 μg/kg just before the scalp incision
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 44
Study: 26840421

Group type: EXPERIMENTAL
Intervention: Experimental intervention (therapeutic Qi stimulation)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control intervention (needle untouched)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Null intervention (no needle inserted)
Number of subjects: 30
Study: 23144449

Group type: EXPERIMENTAL
Intervention: Increased HCQ dose to achieve target [HCQ] ≥1000 ng/ml (group 2)
Number of subjects: 171

Group type: COMPARATOR
Intervention: No daily dose change (group 1)
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Patients at therapeutic target [HCQ] throughout follow-up
Number of subjects: 171
Study: 20617348

Group type: EXPERIMENTAL
Intervention: Miglitol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 18827045

Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT)
Number of subjects: 477

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 477

Group type: EXPERIMENTAL
Intervention: HRT
Number of subjects: 477
Study: 16553240

Group type: EXPERIMENTAL
Intervention: Bivalirudine
Number of subjects: 0
Study: 14616257

Group type: EXPERIMENTAL
Intervention: Supine position
Number of subjects: 18

Group type: COMPARATOR
Intervention: Standing position
Number of subjects: 18
Study: 11382895

Group type: EXPERIMENTAL
Intervention: GHRH (4x50 microgram, at 2200, 2300, 2400 and 0100 h)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 42
Study: 9178335

Group type: EXPERIMENTAL
Intervention: Nortriptyline (50-150 ng/ml)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Nortriptyline
Number of subjects: 68
Study: 1301124

Group type: EXPERIMENTAL
Intervention: Dartmouth COOP Charts used by 29 Chart physicians
Number of subjects: 56

Group type: COMPARATOR
Intervention: No measure of health status used by 27 control clinicians
Number of subjects: 56
Study: 4006345

Group type: EXPERIMENTAL
Intervention: Static contraction (one-arm handgrip and two-leg extension at 30% of maximal voluntary contraction for 3 min)
Number of subjects: 22
Study: 29790478

Group type: EXPERIMENTAL
Intervention: Resting Full-cycle Ratio (RFR)
Number of subjects: 651

Group type: COMPARATOR
Intervention: instantaneous wave‐free ratio (iFR)
Number of subjects: 651
Study: 27612562

Group type: EXPERIMENTAL
Intervention: SCOHP (Stroke and Carer Optimal Health Program)
Number of subjects: 168

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 168
Study: 23316080

Group type: EXPERIMENTAL
Intervention: adalimumab+MTX
Number of subjects: 334

Group type: COMPARATOR
Intervention: MTX alone
Number of subjects: 334
Study: 22334807

Group type: EXPERIMENTAL
Intervention: Bilevel positive airway pressure with pressure release technology (Bi‐Flex)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Standard continuous positive airway pressure (CPAP) therapy
Number of subjects: 56
Study: 21211331

Group type: EXPERIMENTAL
Intervention: Prospective ECG-gated 320-detector CTCA
Number of subjects: 480

Group type: COMPARATOR
Intervention: Retrospective ECG-gated 320-detector CTCA
Number of subjects: 480
Study: 19014164

Group type: EXPERIMENTAL
Intervention: New uncovering technique
Number of subjects: 33

Group type: COMPARATOR
Intervention: Conventional uncovering technique
Number of subjects: 33
Study: 16169338

Group type: EXPERIMENTAL
Intervention: Radial access
Number of subjects: 50

Group type: COMPARATOR
Intervention: Femoral access
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both access sites
Number of subjects: 50
Study: 14567091

Group type: EXPERIMENTAL
Intervention: Margarine with plant sterol esters (30 g/d with 8 g/100 g of product)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Butter (30 g/d)
Number of subjects: 42
Study: 10636618

Group type: EXPERIMENTAL
Intervention: Acute normovolemic hemodilution (ANH)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control (no ANH)
Number of subjects: 34
Study: 8938498

Group type: EXPERIMENTAL
Intervention: Hospital admission on the day of surgery, discharge the day after; two consultations at the outpatient department; one visit by the community nurse before surgery, two visits after.
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Mostly as for 2. with two GP visits replacing the two consultations at the outpatient department.
Number of subjects: 120

Group type: COMPARATOR
Intervention: Traditional hospital stay.
Number of subjects: 120
Study: 1390962

Group type: EXPERIMENTAL
Intervention: Immediate treatment group (psychological treatment package including relaxation training, electromyogram, and thermal biofeedback)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Immediate treatment group
Number of subjects: 8

Group type: COMPARATOR
Intervention: Delayed treatment group
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control group (delayed treatment)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 8
Study: 3883902

Group type: EXPERIMENTAL
Intervention: Topical minoxidil therapy (1.0 mL applied twice a day)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Topical minoxidil therapy
Number of subjects: 56
Study: 31474546

Group type: EXPERIMENTAL
Intervention: Romiplostim 10 μg/kg once weekly
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Romiplostim 6 μg/kg once weekly
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Romiplostim 3 μg/kg once weekly
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Romiplostim 1 μg/kg once weekly
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Romiplostim during weeks 46-53
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Romiplostim at 2 and 3 years
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Treatment-related adverse events
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Adverse events of grade 3 or higher
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Death during treatment
Number of subjects: 35
Study: 29595303

Group type: EXPERIMENTAL
Intervention: Prequestion group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 0
Study: 26449934

Group type: EXPERIMENTAL
Intervention: Psycho-educational group intervention delivered in three sessions by health professionals (physician, nurse, social worker/priest)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Psycho-educational group intervention
Number of subjects: 119

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 119
Study: 25518530

Group type: EXPERIMENTAL
Intervention: Calcium hydroxide paste (CH)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Gutta-percha points containing calcium hydroxide (CH-GP)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Chlorhexidine (CHX-GP)
Number of subjects: 51
Study: 22441892

Group type: EXPERIMENTAL
Intervention: Simvastatin 40 mg daily for 6 months
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Ezetimibe 10 mg daily for 6 months
Number of subjects: 77

Group type: COMPARATOR
Intervention: Control group (normal cholesterol levels)
Number of subjects: 77
Study: 20520776

Group type: EXPERIMENTAL
Intervention: 70% ethanol lock for 15 minutes per day
Number of subjects: 376

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 376

Group type: EXPERIMENTAL
Intervention: 70% ethanol lock
Number of subjects: 376
Study: 17655668

Group type: EXPERIMENTAL
Intervention: CTI ablation (Group CTI+)
Number of subjects: 188

Group type: COMPARATOR
Intervention: LA ablation alone (Group CTI-)
Number of subjects: 188
Study: 11407427

Group type: EXPERIMENTAL
Intervention: Early bilinguals
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Late bilinguals
Number of subjects: 2
Study: 9686470

Group type: EXPERIMENTAL
Intervention: Transvaginal color Doppler ultrasonography
Number of subjects: 140
Study: 8293640

Group type: EXPERIMENTAL
Intervention: Computed tomography (CT)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Magnetic resonance imaging (MRI)
Number of subjects: 58

Group type: COMPARATOR
Intervention: MRI
Number of subjects: 58

Group type: COMPARATOR
Intervention: CT
Number of subjects: 58
Study: 2951871

Group type: EXPERIMENTAL
Intervention: Nifedipine (Adalat; Bayer‐Miles)
Number of subjects: 0
Study: 29340826

Group type: EXPERIMENTAL
Intervention: Single-port laparoscopic surgery (SPLS)
Number of subjects: 180
Study: 26135473

Group type: EXPERIMENTAL
Intervention: Ceramic-on-metal (CoM)
Number of subjects: 390

Group type: COMPARATOR
Intervention: Metal-on-metal (MoM)
Number of subjects: 390
Study: 25428342

Group type: EXPERIMENTAL
Intervention: Kangquan Recipe (KQR)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Cernilton
Number of subjects: 106
Study: 24334318

Group type: EXPERIMENTAL
Intervention: Intrinsic motivation group
Number of subjects: 42

Group type: COMPARATOR
Intervention: Externally regulated motivation group
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 42
Study: 20642376

Group type: EXPERIMENTAL
Intervention: Asthma management intervention
Number of subjects: 90
Study: 18701641

Group type: EXPERIMENTAL
Intervention: Ozone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Iridium
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 17067102

Group type: EXPERIMENTAL
Intervention: Prehospital thrombolysis
Number of subjects: 800

Group type: COMPARATOR
Intervention: Not applicable (control group not specified)
Number of subjects: 800
Study: 14505143

Group type: EXPERIMENTAL
Intervention: Japan's share of articles in gastroenterology and hepatology
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Overall articles from Japan
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Randomized controlled trials (RCTs) from Japan
Number of subjects: 0
Study: 11728269

Group type: EXPERIMENTAL
Intervention: Calcium Heparin (CH) - 12,500 IU subcutaneous daily for 3 months, followed by 325 mg ASA daily for 3 months
Number of subjects: 90

Group type: COMPARATOR
Intervention: Acetylsalicylic Acid (ASA) - 325 mg/day for 6 months
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 90
Study: 8790079

Group type: EXPERIMENTAL
Intervention: Warfarin therapy
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Ping-ponging elicitation method
Number of subjects: 64

Group type: COMPARATOR
Intervention: Starting at the known efficacy method
Number of subjects: 64
Study: 1506947

Group type: EXPERIMENTAL
Intervention: Low-cost education and feedback intervention (brief orientation, pamphlet of cost strategies, detailed interim bills, information about projected length of stay and usual hospital reimbursement)
Number of subjects: 1432

Group type: EXPERIMENTAL
Intervention: Low-cost education and feedback intervention
Number of subjects: 1432

Group type: COMPARATOR
Intervention: Control services
Number of subjects: 1432
Study: 31955002

Group type: EXPERIMENTAL
Intervention: CDDP + S-1
Number of subjects: 102

Group type: COMPARATOR
Intervention: CDDP + PEM
Number of subjects: 102
Study: 30980253

Group type: EXPERIMENTAL
Intervention: Rare disaster information
Number of subjects: 242

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 242
Study: 29138535

Group type: EXPERIMENTAL
Intervention: Eporon® (4,000 IU)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Eprex® (4,000 IU)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Both formulations
Number of subjects: 42